Evidence map›Paper›PMID 26029847›Full record

ArticleAutophagy2015

The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML.

Sandrine Obba, Zoheir Hizir, Laurent Boyer, Dorothée Selimoglu-Buet, Anja Pfeifer, Gregory Michel, Mohamed-Amine Hamouda, Diogo Gonçalvès, Michael Cerezo, Sandrine Marchetti and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Macrophage P2YActa pharmaceutica Sinica. B · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 4 countries.

Sandrine Obbaa Inserm U1065 / C3M, Team 2; Cell Death Differentiation Inflammation and Cancer Nice , France.
Zoheir Hizir
Laurent Boyer
Dorothée Selimoglu-Buet
Anja Pfeifer
Gregory Michel
Mohamed-Amine Hamouda
Diogo Gonçalvès
Michael Cerezo
Sandrine Marchetti
Stephane Rocchi
Nathalie Droin
Thomas Cluzeau
Guillaume Robert
Frederic Luciano
Bernard Robaye
Marc Foretz
Benoit Viollet
Laurence Legros
Eric Solary
Patrick Auberger
Arnaud Jacquel
Inserm · FRLa Ligue Contre le Cancer · FRUniversité Côte d'Azur · FRCentre Hospitalier Universitaire de Nice · FRCentre National de la Recherche Scientifique · FRInstitute of Normal and Pathological Physiology of the Slovak Academy of Sciences · SKSorbonne Paris Cité · FRUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy is induced during differentiation of human monocytes into macrophages that is mediated by CSF1/CSF-1/M-CSF (colony stimulating factor 1 [macrophage]). However, little is known about the molecular mechanisms that link CSF1 receptor engagement to the induction of autophagy. Here we show that the CAMKK2-PRKAA1-ULK1 pathway is required for CSF1-induced autophagy and human monocyte differentiation. We reveal that this pathway links P2RY6 to the induction of autophagy, and we decipher the signaling network that links the CSF1 receptor to P2RY6-mediated autophagy and monocyte differentiation. In addition, we show that the physiological P2RY6 ligand UDP and the specific P2RY6 agonist MRS2693 can restore normal monocyte differentiation through reinduction of autophagy in primary myeloid cells from some but not all chronic myelomonocytic leukemia (CMML) patients. Collectively, our findings highlight an essential role for PRKAA1-mediated autophagy during differentiation of human monocytes and pave the way for future therapeutic interventions for CMML.

Indexed as

AMP-Activated Protein KinasesAnimalsAutophagyCalcium-Calmodulin-Dependent Protein Kinase KinaseCell DifferentiationCell Line, TumorEnzyme ActivationHumansLeukemia, MyeloidMacrophage Colony-Stimulating FactorMice, Inbred C57BLModels, BiologicalMonocytesPhospholipase C gammaReceptors, Purinergic P2Signal TransductionAMP-Activated Protein KinasesCalcium-Calmodulin-Dependent Protein Kinase KinaseCAMKK2 protein, humanMacrophage Colony-Stimulating FactorPhospholipase C gammapurinoceptor P2Y6Receptors, Purinergic P2Uridine DiphosphateACTB actin, βapoptosis-related cysteine peptidaseautophagyCAMKK2, calcium/calmodulin-dependent protein kinase kinase 2, βCASP8, caspase 8CFLAR CASP8 and FADD-like apoptosis regulatorCMMLCMML chronic myelomonocytic leukemiaCSF1CSF1 colony stimulating factor 1 (macrophage)CSF1R colony stimulating factor 1 receptorDEFA1 defensin α 1DEFA3 defensin α 3 neutrophil-specificdifferentiationDRS; dorsomorphinEMR1 EGF-like module-containing mucin-like hormone receptor-like 1FADD Fas (TNFRSF6)-associated via death domainG-protein coupled 6ITGAM integrin α MMAP1LC3B/LC3B microtubule-associated protein 1 light chain 3 βP2RY6P2RY6 pyrimidinergic receptor P2YPLCB3 phospholipase CPLCG2 phospholipase C gamma 2 (phosphatidylinositol-specific)PLC phospholipaseprimary monocytePRKAA1/AMPKα1PRKAA1 protein kinase AMP-activated α 1 catalytic subunitPRKAA2 protein kinase AMP-activated α 2 catalytic subunitPRKAA protein kinase AMP-activatedPRKAG1 protein kinase AMP-activated gamma 1 noncatalytic subunitRIPK1 receptor (TNFRSF)-interacting serine-threonine kinase 1STK11 serine/threonine kinase 11TFRC transferrin receptorUDP uridine diphosphateULK1 unc-51 like autophagy activating kinase 1WT wild-typeβ 3 (phosphatidylinositol-specific)

Identifiers

PMID26029847
PMCPMC4590592
OpenAlexW2139175045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.